From stratification to therapy

Metabolic pathways rather than organs

First universal digital twin in oncology paving the way for effective oncology based on pan-cancer stratification

More patients can benefit from your therapy

pharmaceuticals : You have an anti-cancer targeted molecule in clinical phase 1. or a drug already on the market. Let’s work together to identify all possible repositioning opportunities.

Biotech companies : You have an anti-cancer targeted molecule in clinical phase 1. Let’s work together to identify all possible repositioning opportunities.

Our product range

Repositioning and repurposing of targeted therapies

They support us

  • UPCité
  • CNRS
  • INCA
  • Erganéo
  • Paris Biotech Santé
  • France 2030